In case you missed it: November 7 to November 11
A look back at the week's headlines.
A wave of change: How EMIGS is altering the surgical training landscape
Nash Moawad, MD, MS, FACOG, FACS, sits down to discuss the recent standardization of Essentials of Minimally Invasive Gynecologic Surgery (EMIGS) training program for minimally invasive gynecologic surgeons and how it's shaping the way this subspecialty delivers care.
November is for diabetes awareness
November is Diabetes Awareness Month.
2023 women's health outlook
Alison Cowan, MD, discusses her predictions for women's health trends in 2023.
Inside the November issue of Contemporary OBGYN
Take a look inside this month's issue.
Efficacy of N. sativa-honey vs. clotrimazole for VVC
A study published in the journal Evidence-Based Complementary and Alternative Medicine found that both Nigella sativa (N. sativa) (black seed and black cumin)-honey vaginal cream and the antifungal medication clotrimazole significantly improve the symptoms of vulvovaginal candidiasis (VVC).
Highlights from the 25th Annual Premier Women’s Healthcare Conference
Houston, Texas, was buzzing with the latest updates in women’s health at the 25th Annual Nurse Practitioners in Women’s Health Premier Women’s Healthcare Conference held from September 29 to October 2, 2022.
Readers React: Neutral language has adverse effects
A reader writes in to the editors.
Buprenorphine use in pregnancy linked to decreased fetal breathing movements
May 18th 2024According to a poster presented at ACOG 2024, use of the synthetic opioid buprenorphine depressed fetal breathing in biophysical profile assessments, but had no significant impact on other factors like amniotic fluid index or fetal tone.
Read More
